quisqualic acid has been researched along with Alzheimer Disease in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellucci, A; Casamenti, F; Giovannini, MG; Pepeu, G; Prosperi, C; Scali, C | 1 |
Casamenti, F; Pepeu, G; Prosperi, C; Scali, C; Vannucchi, MG | 1 |
Dragunow, M; Faull, RL; Jansen, KL; Synek, BL | 1 |
Agid, Y; Brice, A; Duyckaerts, C; Hauw, JJ; LeMoal, M; Mayo, W; Ruberg, M; Simon, H | 1 |
4 other study(ies) available for quisqualic acid and Alzheimer Disease
Article | Year |
---|---|
The selective cyclooxygenase-2 inhibitor rofecoxib suppresses brain inflammation and protects cholinergic neurons from excitotoxic degeneration in vivo.
Topics: Alzheimer Disease; Animals; Astrocytes; Brain; Cell Death; Choline O-Acetyltransferase; Cholinergic Fibers; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Encephalitis; Gliosis; Isoenzymes; Lactones; Male; Microglia; Mitogen-Activated Protein Kinases; Nerve Degeneration; Neurons; Neuroprotective Agents; Neurotoxins; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Prostaglandin-Endoperoxide Synthases; Quisqualic Acid; Rats; Rats, Wistar; Sulfones | 2003 |
Brain inflammatory reaction in an animal model of neuronal degeneration and its modulation by an anti-inflammatory drug: implication in Alzheimer's disease.
Topics: Acetylcholine; Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Choline O-Acetyltransferase; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; Encephalitis; Excitatory Amino Acid Agonists; gamma-Aminobutyric Acid; Gliosis; Interleukin-1; Isoenzymes; Male; Microscopy, Electron; Nerve Degeneration; Neurons; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Prostaglandin-Endoperoxide Synthases; Quisqualic Acid; Rats; Rats, Wistar; Sulfonamides | 2000 |
Alzheimer's disease: changes in hippocampal N-methyl-D-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opioid receptors--an autoradiographic study.
Topics: Aged; Alzheimer Disease; Autopsy; Autoradiography; Hippocampus; Humans; Neurotensin; Pyramidal Tracts; Quisqualic Acid; Receptors, AMPA; Receptors, GABA-A; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotensin; Receptors, Neurotransmitter; Receptors, Opioid; Receptors, Purinergic; Receptors, Serotonin; Reference Values; Tritium | 1990 |
Choline acetyltransferase activity and [3H]vesamicol binding in the temporal cortex of patients with Alzheimer's disease, Parkinson's disease, and rats with basal forebrain lesions.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Animals; Brain Injuries; Choline O-Acetyltransferase; Female; Humans; Hydroxydopamines; Kinetics; Male; Neuromuscular Depolarizing Agents; Oxadiazoles; Oxidopamine; Parkinson Disease; Phencyclidine; Piperidines; Quisqualic Acid; Rats; Rats, Inbred Strains; Receptors, Neurotransmitter; Receptors, Phencyclidine; Reference Values; Substantia Nigra; Temporal Lobe | 1990 |